+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast

  • ID: 4210273
  • Report
  • April 2017
  • Region: Europe, Italy, Malta, Portugal, Spain
  • 81 Pages
  • Renub Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
It is Predicted that the Seasonal Influenza Vaccine Market Will Increase to US$ 209.1 Million by the Year 2022

According to this report 'Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast', in the Southern European countries, Italy is having the highest seasonal influenza vaccine market share followed by Spain. In terms of children vaccination, Italy & Spain holds more than 80 percent market share whereas, in adult vaccination segments, these two will share more than 90 percent market share by 2022.

This report provides a complete analysis of 4 Southern European Countries (Italy, Malta, Portugal and Spain) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022.

All the 4 countries in the report have been studied from 2 viewpoints:

1. Seasonal Influenza Vaccine Market in Southern Europe Countries (2011 - 2022)

  • Seasonal Influenza Vaccine Market & Forecast
  • Children Seasonal Influenza Vaccine Market & Forecast
  • Adult Seasonal Influenza Vaccine Market & Forecast

2. Seasonal Influenza Vaccinated Population in Southern Europe Countries (2011 - 2022)

  • Seasonal Influenza Vaccinated Population & Forecast
  • Children Seasonal Influenza Vaccinated Population & Forecast
  • Adult Seasonal Influenza Vaccinated Population & Forecast

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 4

1. Executive Summary

2. Southern European Countries Seasonal Influenza Vaccinated Total Population
2.1 Seasonal Influenza Vaccinated Child Population in Southern European Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Southern European Countries

3. Southern European Countries Seasonal Influenza Vaccine Market
3.1 Seasonal Influenza Child Vaccine Market in Southern Europe Countries
3.2 Seasonal Influenza Adult Vaccine Market in Southern Europe Countries

4. Southern Europe Countries Seasonal Influenza Vaccine Market Share
4.1 Southern Europe Countries Seasonal Influenza Vaccine Market Share
4.2 Southern Europe Countries Seasonal Influenza Child Vaccine Market Share
4.3 Southern Europe Countries Seasonal Influenza Adult Vaccine Market Share

5. Italy
5.1 Italy Seasonal Influenza Vaccinated Total Population
5.1.1 Italy Seasonal Influenza Vaccinated Child Population
5.1.2 Italy Seasonal Influenza Vaccinated Adult Population
5.2 Italy Seasonal Influenza Vaccine Market
5.2.1 Italy Seasonal Influenza Child Vaccine Market
5.2.2 Italy Seasonal Influenza Adult Vaccine Market

6. Malta
6.1 Malta Seasonal Influenza Vaccinated Total Population
6.1.1 Malta Seasonal Influenza Vaccinated Child Population
6.1.2 Malta Seasonal Influenza Vaccinated Adult Population
6.2 Malta Seasonal Influenza Vaccine Market
6.2.1 Malta Seasonal Influenza Child Vaccine Market
6.2.2 Malta Seasonal Influenza Adult Vaccine Market

7. Portugal
7.1 Portugal Seasonal Influenza Vaccinated Total Population
7.1.1 Portugal Seasonal Influenza Vaccinated Child Population
7.1.2 Portugal Seasonal Influenza Vaccinated Adult Population
7.2 Portugal Seasonal Influenza Vaccine Market
7.2.1 Portugal Seasonal Influenza Child Vaccine Market
7.2.2 Portugal Seasonal Influenza Adult Vaccine Market

8. Spain
8.1 Spain Seasonal Influenza Vaccinated Total Population
8.1.1 Spain Seasonal Influenza Vaccinated Child Population
8.1.2 Spain Seasonal Influenza Vaccinated Adult Population
8.2 Spain Seasonal Influenza Vaccine Market
8.2.1 Spain Seasonal Influenza Child Vaccine Market
8.2.2 Spain Seasonal Influenza Adult Vaccine Market

9. Seasonal Influenza Vaccine - Growth Drivers
9.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
9.2 Declining Child Population & Accelerating Ageing Population in Southern European Region
9.3 Rising Healthcare Expenditure Share of the Southern Europe Countries GDP

10. Seasonal Influenza Vaccine - Challenges
10.1 Regulatory Challenges with New and Novel Influenza Vaccines
10.2 Lack of Healthcare Infrastructure
10.3 Limited Reimbursement and Access to the Vaccines

List of Figures
Figure 2 1: Southern Europe Countries - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 2 2: Southern Europe Countries - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 2 3: Southern Europe Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Southern Europe Countries - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Southern Europe Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Southern Europe Countries - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Southern Europe Countries - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 3 2: Southern Europe Countries - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 3 3: Southern Europe Countries - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 3 4: Southern Europe Countries - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 3 5: Southern Europe Countries - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 3 6: Southern Europe Countries - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 4 1: Southern Europe Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Southern Europe Countries - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Southern Europe Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Southern Europe Countries - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Southern Europe Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Southern Europe Countries - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Italy - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Italy - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Italy - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Italy - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Italy - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Italy - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 5 8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 5 9: Italy - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 5 10: Italy - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 5 11: Italy - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 5 12: Italy- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 6 1: Malta - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Malta - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Malta - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Malta - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Malta - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Malta - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Malta - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Malta - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Malta - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Malta - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 11: Malta - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 12: Malta - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Portugal - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: Portugal - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: Portugal - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Portugal - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Portugal - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Portugal - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Portugal - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 7 8: Portugal - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 7 9: Portugal - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 7 10: Portugal - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 7 11: Portugal - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 7 12: Portugal - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 8 1: Spain - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Spain - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Spain - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Spain - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Spain - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Spain - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Spain - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 8 8: Spain - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 8 9: Spain -Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 8 10: Spain - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 8 11: Spain - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 8 12: Spain - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 9 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
Figure 9 2: Southern Europe Countries - Child Population (Thousand), 2010 - 2016
Figure 9 3: Southern Europe Countries - Forecast for Child Population (Thousand), 2017 - 2022
Figure 9 4: Southern Europe Countries - Ageing Population (Thousand), 2010 - 2016
Figure 9 5: Southern Europe Countries - Forecast for Ageing Population (Thousand), 2017 - 2022
Figure 10 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019

List of Tables
Table 9 1: Southern Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015

Note: Product cover images may vary from those shown
3 of 4
  • Italy
  • Malta
  • Portugal
  • Spain
Note: Product cover images may vary from those shown
4 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll